CLGN

NASDAQ · Biotechnology

Collplant Biotechnologies Lt

Penny Stocks Biotech Stocks Healthcare Stocks

$4.64

+0.68 (+17.17%)

As of Nov 14, 2:47 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +270.5% upside

Low Target $14.35

Average Target $17.19

High Target $29.92

Current Price $4.64

Current
$4.64

Target
$17.19

$14.35 $17.19 avg $29.92

Scenario Analysis

Bear Case

$14.35

209.3%

Low target

Base Case

$17.19

+270.5%

Avg target

Bull Case

$29.92

+544.8%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$22.50

-79.4% from high

52-Week Low

$2.64

+75.8% from low

Target vs 52W High

$17.19

-23.6% vs high

Next Earnings Report

Nov 24, 2026

until earnings

EPS Est: $-0.13

Earnings in 9 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%